Table 1.
Demographic and clinical characteristics of People Living With HIV at the time of biopsy. (N) denotes the number of people with available data. Body mass index (BMI), Highly Active Anti-Retroviral therapy (ART), Tenofovir Disoproxil Fumerate (TDF), Tenofovir Alafenamide (TAF)
| Characteristic (N) | Mean (SD) or n (%) | |
|---|---|---|
| Gender (19) | Male | 16 (84%) |
| Female | 3 (16%) | |
| Age (19) | 48 years (SD 13) | |
| Country of Origin (19) | Australia | 10 (53%) |
| India | 2 (11%) | |
| China | 2 (11%) | |
| Thailand | 1 (5%) | |
| Hungary | 1 (5%) | |
| Philippines | 1 (5%) | |
| Samoa | 1 (5%) | |
| America | 1 (5%) | |
| Smoking status (15) | Current smoker | 7 (47%) |
| Ex-smoker | 2 (13%) | |
| Never smoked | 6 (40%) | |
| Illicit drug use (12) | Ecstasy | 1 (8%) |
| Amphetamines | 1 (8%) | |
| Ecstasy and amphetamines | 1 (8%) | |
| Heroin | 1 (8%) | |
| None | 8 (68%) | |
| BMI (15) | 26 kg/m2 (SD 6) | |
| Years on ART (15) | 9 years (SD 8) | |
| Tenofovir-based ART (19) | TDF | 3 (16%) |
| TAF | 9 (47%) | |
| non-tenofovir ART | 6 (32%) | |
| nil ART | 1 (5%) | |
| Co-morbidities (19) | Diabetes Mellitus | 4 (21%) |
| Hypertension | 15 (74%) | |
| Clinical Features (19) | ||
| Decreased eGFR + proteinuria + haematuria | 6 (32%) | |
| Decreased eGFR + proteinuria | 5 (26%) | |
| Proteinuria + haematuria | 3 (16%) | |
| Decreased eGFR alone | 3 (16%) | |
| Proteinuria alone | 2 (10%) | |